Programming settings and recharge interval in a prospective study of a rechargeable sacral neuromodulation system for the treatment of overactive bladder

Publisher： John Wiley & Sons Inc

E-ISSN： 1520-6777|37|S2|S17-S22

ISSN： 0733-2467

Source： NEUROUROLOGY AND URODYNAMICS, Vol.37, Iss.S2, 2018-02, pp. : S17-S22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Three month clinical results with a rechargeable sacral neuromodulation system for the treatment of overactive bladder

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 37, Iss. S2, 2018-02 ,pp. : S9-S16

John Wiley & Sons Inc

Access to resources Recommend Favorite

Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6‐months in subjects with mild symptoms of overactive bladder

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 34, Iss. 3, 2015-03 ,pp. : 224-230

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Information on Sacral Neuromodulation and Botulinum Toxin Treatment for Refractory Idiopathic Overactive Bladder Syndrome: A Review

By  

Urologia Internationalis, Vol. 84, Iss. 3, 2010-04 ,pp. : 245-253

Karger

Access to resources Recommend Favorite

The novel Axonics® rechargeable sacral neuromodulation system: Procedural and technical impressions from an initial North American experience

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 37, Iss. S2, 2018-02 ,pp. : S1-S8

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Safety and Efficacy of Two Different Antimuscarinics, Imidafenacin and Solifenacin, for Treatment of Overactive Bladder: A Prospective Randomized Controlled Study

By  

Urologia Internationalis, Vol. 90, Iss. 2, 2012-11 ,pp. : 161-167

Karger

Access to resources Recommend Favorite